Corrigendum to ‘Thalidomide Attenuates Graft Arteriosclerosis of Aortic Transplant in a Rat Model’ (Thalidomide Attenuates Graft Arteriosclerosis of Aortic Transplant in a Rat Model (2011) 43(5) (2022–2026), (S0041134511006014), (10.1016/j.transproceed.2011.03.086));Thalidomide attenuates graft arteriosclerosis of aortic transplant in a rat model

Transplantation Proceedings

Volumn 43, Issue 5, 2011, Pages 2022-2026

  Zhang, Y ^a   Yang, M ^a   Yang, Y ^a   Zheng, S L ^a   Cai, Y ^a   Xia, P ^a   Chen, W W ^a   Chen, B C ^a   Yang, Y R ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; PLATELET DERIVED GROWTH FACTOR; THALIDOMIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTIC GRAFT ARTERIOSCLEROSIS; ARTERIOSCLEROSIS; ARTICLE; BLOOD SAMPLING; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT DYSFUNCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 79959442262     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2022.03.004     Document Type: Erratum

References (31)

1. M. Weis, and W. von Scheidt Cardiac allograft vasculopathy Circulation 16 1997 2069
2. M.E. Franks, G.R. Macpherson, and W.D. Figg Thalidomide Lancet 363 2004 1802
3. S. Singhal, and J. Mehta Thalidomide in cancer Biomed Pharmacother 56 2002 4
4. D.M. McCarthy, E. Kanfer, and J. Taylor Thalidomide for graft-versus-host disease Lancet ii 1988 1135
5. D. Heney, D.R. Norfolk, and J. Wheeldon Thalidomide treatment for chronic graft-versus-host disease Br J Haematol 78 1991 23
6. J.B.V. Carvalho, A. Petroianu, and E. Travolo Effects of immunosuppression induced by thalidomide and cyclosporine in heterotopic heart transplantation in rabbits Transplant Proc 39 2007 1640
7. K. Lietz, and L.W. Miller Current understanding and management of allograft vasculopathy Semin Thorac Cardiovasc Surg 16 2004 386
8. P. Libby, and J.S. Pober Chronic rejection Immunity 14 2001 387
9. F.L. Celletti, J.M. Waugh, and P.G. Amabile Vascular endothelial growth factor enhances atherosclerotic plaque progression Nat Med 7 2001 425
10. K.B. Lemstrom, R. Krebs, and A.I. Nykanen Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis Circulation 105 2002 2524
11. M.E. Reinders, J.C. Fang, and W. Wong Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection Transplantation 76 2003 224
12. L.P. Abramson, E. Pahl, and L. Huang Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation Transplantation 73 2002 153
13. H.L. Pilmore, J.M. Eris, and D.M. Painter Vascular endothelial growth factor expression in human chronic renal allograft rejection Transplantation 67 1999 929
14. R.J. Torry, C.A. Labarrere, and D.S. Torry Vascular endothelial growth factor expression in transplanted human hearts Transplantation 60 1995 1451
15. M.E. Reinders, M. Sho, and A. Izawa Proinflammatory functions of vascular endothelial growth factor in alloimmunity J Clin Invest 112 2003 1655
16. K.B. Lemstrom, R. Krebs, and Al Nykanen Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis Circulation 105 2002 2524
17. C.H. Heldin, and B. Westermark Mechanism of action and in vivo role of platelet-derived growth factor Physiol Rev 79 1999 1283
18. M. Hellstrom, M. Kalen, and P. Lindahl Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse Development 126 1999 3047
19. R. Ross, J. Masuda, and E.W. Raines Localization of PDGF-B protein in macrophages in all phases of atherogenesis Science 248 1990 1009
20. R. Sihvola, P. Koskinen, and M. Myllarniemi Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor Circulation 99 1999 2295
21. K.B. Lemstrom, and P.K. Koskinen Expression and localization of platelet-derived growth factor ligand and receptor protein during acute and chronic rejection of rat cardiac allografts Circulation 96 1997 1240
22. U.W. Heemann, S.G. Tullius, and H. Azuma Adhesion molecules and transplantation Ann Surg 219 1994 4
23. S.M. Schwartz Smooth muscle migration in vascular development and pathogenesis Transplant Immunol 5 1997 255
24. G.B. Vogelsang, E.R. Farmer, and A.D. Hess Thalidomide for the treatment of chronic graft-versus-host disease N Engl J Med 327 1992 735
25. G.B. Vogelsang, M.C. Wells, and G.W. Santos Combination low-dose thalidomide and cyclosporine prophylaxis for acute graft-versus-host disease in a rat mismatched model Transplant Proc 20 2 suppl 2 1988 226
26. G.B. Vogelsang, A.D. Hess, and G. Gordon Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model Transplantation 41 1986 644
27. G.B. Vogelsang, A.D. Hess, and K.J. Friedman Therapy of chronic graft-v-host disease in a rat model Blood 74 1989 507
28. F. Tamura, G.B. Vogelsang, and B.A. Reitz Combination thalidomide and cyclosporine for cardiac allograft rejection: comparison with combination methylprednisolone and cyclosporine Transplantation 49 1990 20
29. K. Uthoff, K.J. Zehr, and P.B. Gaudin Thalidomide as replacement for steroids in immunosuppression after lung transplantation Ann Thorac Surg 59 1995 277
30. J.B. Carvalho, A. Petroianu, and E. Travolo Effects of immunosuppression induced by thalidomide and cyclosporine in heterotopic heart transplantation in rabbits Transplant Proc 39 2007 1640
31. S. Zhang, M. Li, and Y. Gu Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma J Exp Clin Cancer Res 27 2008 60